Frank Quinn to Rejoin Align Technology as Executive Vice President and Managing Director of the Americas Region

ALGN 10.23.2024

Full Press ReleaseSEC FilingsOur ALGN Tweets

About Gravity Analytica

Recent News

  • 02.05.2025 - Align Technology Fourth Quarter and Full Year 2024 Earnings Call
  • 01.16.2025 - Align Technology Announces NFL Quarterback Patrick Mahomes Joins the Invisalign Brand Smile Squad
  • 01.02.2025 - Align Technology to Announce Fourth Quarter and 2024 Results on February 5, 2025

Recent Filings

  • 11.25.2024 - 144 Report of proposed sale of securities

TEMPE, Ariz.--(BUSINESS WIRE)--Oct. 23, 2024--Align Technology, Inc.(Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTeroTM intraoral scanners, and exocadTM CAD/CAM software for digital orthodontics and restorative dentistry, today announcedFrank Quinn, formerly Align vice president and general manager ofthe United States, will rejoin the company as executive vice president and managing director of theAmericasregion, reporting toJoe Hogan, Align president and CEO. As part of the global organizational restructuring plan that the company announced separately today, Raj Pudipeddi’s position as executive vice president and managing director of theAmericasregion and chief marketing officer has been eliminated and he will leave Align in the fourth quarter of 2024.

Commenting on today’s announcement,Joe Hogan,Align Technologypresident and CEO said, “I am pleased to welcomeFrank Quinnback to Align as the EVP and Managing Director,Americas. Frank’s experience, deep understanding of the orthodontic and dental industries, and insights into what digital means for our doctor customers is key and he is excited to be rejoining the company. He is a well-established leader with a solid customer focus and proven track record, and I am confident Frank will help facilitate growth and adoption of our products and drive focused execution across theAmericasregion. We thank Raj for his contributions to Align over the past 5+ years in leading our marketing and product innovation/management as well as overseeing the APAC andAmericasregions and we wish Raj well.”

Frank Quinn, Executive Vice President and Managing Director,Americas

Frank Quinnserves as the Executive Vice President and Managing Director of theAmericasregion. He has responsibility for market development and operational execution of allAlign Technologyproducts and services in theAmericasregion.Mr. Quinnre-joined Align inOctober 2024after spending two years at LightForce Orthodontics, where he served as Chief Revenue Officer. Prior to his role at LightForce,Mr. Quinnspent nearly 9 years at Align serving in multiple roles including Vice President and General Manager, where he was responsible for driving continued growth and profitability forthe United States. During his time at Align, Mr. Quinn’s other positions included Senior Sales Director of Special Markets and iTero, Vice President of Special Markets, Business Development and Education.Mr. Quinnhas a wealth of experience driving growth, strategy and revenue in the orthodontics industry. As a successful executive leader across the medical and technology industries, he combines strong sales leadership experience with expertise in business development, innovation, professional education, commercial operations and culture building.Mr. Quinnhas also served as a Board Member of theAmerican Association of Orthodontics Foundation(AAOF) and theAmerican Academy of Clear Aligners(AACA). He holds a BS in Business Administration and Marketing fromMontclair State University.

AboutAlign Technology, Inc.

Align Technologydesigns and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTeroTM intraoral scanners and services, and exocadTM CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 271 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 27 years, Align has helped doctors treat approximately 18.9 million patients with the Invisalign System and is driving the evolution in digital dentistry through the AlignTM Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visitwww.aligntech.comfor more information.

For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visitwww.invisalign.com. For additional information about the iTero digital scanning system, please visitwww.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visitwww.exocad.com.

Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks ofAlign Technology, Inc.

Forward-Looking Statements

This news release contains forward-looking statements, including statements of beliefs and expectations regarding our ability to successfully control our business and operations and pursue our strategic growth drivers, our expectations for market opportunities, our expectations for the growth and adoption of our products and commercial execution across theAmericasregion, and other matters discussed in this news release that are not purely historical data. Forward-looking statements contained in this news release relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements reflect our best judgments based on currently known facts and circumstances and are subject to risks, uncertainties, and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement.

Factors that might cause such a difference include, but are not limited to:

  • macroeconomic conditions, including inflation, fluctuations in currency exchange rates, high interest rates, market volatility, weakness in general economic conditions and recessions and the impact of efforts by central banks and federal, state and local governments to combat inflation and recession;
  • customer and consumer purchasing behavior and changes in consumer spending habits as a result of, among other things, prevailing macroeconomic conditions, levels of employment, salaries and wages, debt obligations, discretionary income, inflationary pressure, declining consumer confidence, and the military conflict inUkraineand in theMiddle East;
  • variations in our geographic, channel and product mix, product adoption, and selling prices regionally and globally, including product mix shifts to lower priced products or to products with a higher percentage of deferred revenue;
  • competition from existing and new competitors;
  • declines in, or the slowing of the growth of, sales of our clear aligners and intraoral scanners domestically and/or internationally and the impact either would have on the adoption of Invisalign products;
  • the economic and geopolitical ramifications of the military conflict in theMiddle EastandUkraine, including trade disruptions, tariffs, sanctions, or boycotts, retaliatory sanctions, nationalism, supply chain disruptions and other consequences, any of which could adversely impact our operations and assets;
  • the possibility that the development and release of new products or enhancements to existing products do not proceed in accordance with the anticipated timeline or may themselves contain bugs, errors or defects in software or hardware requiring remediation and that the market for the sale of these new or enhanced products may not develop as expected;
  • the timing and availability and cost of raw materials, components, products and other shipping and supply chain constraints and disruptions;
  • unexpected or rapid changes in the growth or decline of our domestic and/or international markets;
  • rapidly evolving and groundbreaking advances that fundamentally alter the dental industry or the way new and existing customers market and provide products and services to consumers;
  • the willingness and ability of our customers to maintain and/or increase product utilization in sufficient numbers;
  • the risks relating to our ability to sustain or increase profitability or revenue growth in future periods (or minimize declines) while controlling expenses;
  • expansion of our business and products;
  • the impact of excess or constrained capacity at our manufacturing and treat operations facilities and pressure on our internal systems and personnel;
  • the compromise of our systems or networks, including any customer and/or patient data contained therein, for any reason;
  • the timing of case submissions from our doctor customers within a quarter as well as an increased manufacturing costs per case; and
  • the loss of key personnel, labor shortages or work stoppages for us or our suppliers.

The foregoing and other risks are detailed from time to time in our periodic reports filed with theSecurities and Exchange Commission("SEC"), including, but not limited to, our Annual Report on Form 10-K for the year endedDecember 31, 2023, which was filed with theSEConFebruary 28, 2024and our latest Quarterly Report on Form 10-Q for the quarter endedJune 30, 2024, which was filed with theSEConAugust 2, 2024. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241023839496/en/

Align TechnologyMadelyn Valente(909) 833-5839mvalente@aligntech.com

Zeno GroupSarah Johnson(828) 551-4201sarah.johnson@zenogroup.com

Source:Align Technology, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com